Laboratory Reference Grade Compounds
Multi-Compound Research Bundles

BPC-157 + TB-500 Stack (Dual-Vial Tissue Repair Kit)

RUO In-VitroLyophilized Powder≥99% Reference Standard
Protocol SOP↓
₱4,250.00
Out of stock
InclusionVial + BAC Water
Net Content10MG
1
BPC-157 + TB-500 Stack (Dual-Vial Tissue Repair Kit)10MG · Vial + BAC Water
₱4,250.00
1
Technical Specification & Protocol Dossier

Analytical Standards & Laboratory Handling

Verified laboratory protocols, reconstitution parameters, and handling guidelines.

P

Pharmacological Profile & Mechanism of Action

Research Monograph

What it is: A premier dual-vial musculoskeletal tissue repair research stack combining BPC-157 (5mg gastric pentadecapeptide) and TB-500 (5mg Thymosin β4 synthetic standard) in two separate sterile analytical vials.

How it works: BPC-157 acts locally at injury sites by upregulating vascular endothelial growth factor (VEGF) and Early Growth Response 1 (EGR-1) to build new microvascular beds and organize collagen fibers. Simultaneously, TB-500 acts systemically by sequestering G-actin into F-actin polymers, driving rapid cellular migration of fibroblasts and stem cells directly to damaged tendons, ligaments, and muscle.

CRITICAL LABORATORY RECONSTITUTION & ASSAY HANDLING: Each constituent vial must be reconstituted separately in its own 2.0 mL Bacteriostatic Water volume. Administer in separate experimental channels or distinct transfer needles to prevent cross-vial solution contamination.

Compound & Molecular Specifications

Certificate of Analysis Standards
Target CategoryMulti-Peptide Blends
Intended ApplicationLaboratory & In-Vitro Research Only (RUO)
Physical StateLyophilized Solid Powder
Purity Specification≥99.0% (Dual Individual HPLC Certified)
Net Content Options10MG
Inclusion PackagesVial Only, Vial + BAC Water, Analytical Lab Set
⚡ Pharmacodynamic Synergy·Verified Stacking Regimens

Frequently Stacked with BPC-157 (Pentadecapeptide)

Clinically verified combinations activating complementary physiological pathways without receptor competition.

Stacking Studio
Co-Administered Regimen

TB-500 (Thymosin Beta-4 Frag)

+98 Synergy
The Wolverine Stack: Dual Microvascular & Actin Remodeling Synergy

BPC-157 acts locally by accelerating microvascular angiogenesis via VEGFR2 and stabilizing granulation tissue, while TB-500 sequesters G-actin to drive rapid systemic cell migration and prevent fibrous adhesion/scar formation.

⏱In-vitro assay titration protocol•🛡Separate syringe
15% Off bundle
Compare
Co-Administered Regimen

GHK-Cu (Copper Tripeptide-1)

+93 Synergy
Microvascular & Extracellular Matrix Remodeling Synergy

BPC-157 rapidly generates fresh capillary networks (angiogenesis) to deliver oxygen and amino acids to damaged tissue, while GHK-Cu signals fibroblasts to synthesize new type I/III collagen and elastin while inhibiting TGF-beta scar formation.

⏱Administer in separate SubQ injections daily•🛡Separate syringe
15% Off bundle
Compare
Co-Administered Regimen

Tirzepatide

+91 Synergy
Incretin GI Tolerance & Mucosal Cytoprotection Stack

GLP-1 receptor agonists can cause transient delayed gastric emptying, nausea, and mucosal irritation. BPC-157 provides direct cytoprotective benefits across gastric epithelium, reducing gut discomfort while incretins drive metabolic weight loss.

⏱Tirzepatide: Weekly SubQ•🛡Separate syringe
15% Off bundle
Compare
Co-Administered Regimen

Semaglutide

+90 Synergy
GLP-1 Gut Barrier & Epithelial Recovery Stack

Semaglutide delays gastric motility to enhance satiety. BPC-157 upregulates tight junction proteins (Claudin, Zonula Occludens) and nitric oxide synthesis, minimizing digestive cramping and acid reflux in GLP-1 naive subjects.

⏱Semaglutide: Weekly SubQ•🛡Separate syringe
15% Off bundle
Compare